Several Catawba Research teammates recently participated in a trial for a COVID-19 vaccine. In this episode of Catawba Talks, we check in on their stories and hear how their experiences brought ground-breaking studies even closer to home.
Shannon Weatherly, Zaidoon A. Al-Zubaidy, Stephanie Al-Zubaidy, Kevin Keller and McKayla Abraham
On this episode of Catawba Talks, we sit down to discuss the trial experience of our Chief Scientific Officer Jack McLane. He comes to Catawba Research with a long career in clinical trials, including work on the original NDA for Accutane. He says he's been a scientist his entire life. No matter his title, he still lists "scientist" as his occupation.
Shannon Weatherly, Zaidoon A. Al-Zubaidy and Jack McLane
The Catawba Research team continues to grow in exciting ways. Join us on this episode of Catawba Talks as we sit down with our new Senior Director of Business Development – Vince Scamacca – to hear his approach to forging strong relationships with clients. Vince discusses his "team effort" philosophy to closing projects and earning sponsor trust.
Zaidoon A. Al-Zubaidy, Vince Scamacca and Shannon Weatherly
While your Catawba Research team slowly transitions back from remote work to office life in the “new norm,” Shannon and Zaidoon chat about the organization’s continued global growth. From new clinical trials and bid defenses to the ongoing evolution of Catawba Research India, it’s busy times around here!
Shannon Weatherly and Zaidoon A. Al-Zubaidy
In this remote episode of Catawba Talks, we chat about the adjustments made by our team and how we’ve successfully grown during the challenge of COVID-19. Sit down with us to hear updates on recently awarded trials, new indications, and our overall push forward!
Shannon Weatherly and Zaidoon A. Al-Zubaidy
Join us as we explore how our CRO has adjusted to keep its team safe and still overdeliver for our clients during the COVID-19 pandemic. Of course, we do so remotely! Check-in with your Catawba Research team and hear our approach to the whole quarantine situation.
Zaidoon A. Al-Zubaidy and Shannon Weatherly
In this episode, we chat remotely with Catawba Research’s Director of Quality Assurance Kelly Field about how the FDA is handling clinical trials during the COVID-19 pandemic. Kelly breaks down the new FDA guidance, discussing how it addresses subject safety, compliance with GCP and other areas during this time of stay-at-home restrictions.
Shannon Weatherly, Kelly Field and Zaidoon A. Al-Zubaidy
On this episode, we talk with one of Catawba Research’s amazing CRAs, Loren Guzman. Listen as we chat about life on the road, how she tackles site audits with tact, why she’s known as the “Query Queen,” and how her work helps steer the success of our clinical trials.
Zaidoon A. Al-Zubaidy, Shannon Weatherly and Loren Guzman
Chris Driskill, a Catawba Research Project Manager, joins us to offer some high-level insights on one of our larger trials to date. Chris dives into his notes – and tiny handwriting – to shed light on the rosacea study, which spanned some 33 sites and included 1,116 patients. Hear Chris discuss how the team covered a lot of trial ground to knock out a roughly nine-month turnaround!
Zaidoon A. Al-Zubaidy, Chris Driskill and Shannon Weatherly
Listen as we discuss Catawba Research’s focus on 505(b)(2) clinical trials. With this accelerated trial pathway comes many benefits not just for sponsors, but for those needing these medications now. Join us in this episode as we map out our adventures in the 505(b)(2) equation for 2020 and ahead.
Zaidoon A. Al-Zubaidy and Shannon Weatherly
